Barbiturates are a class of sedative drugs that slow down the central nervous system. First synthesized in 1864 and introduced into medicine in the early 1900s, they were once among the most widely prescribed medications in the world. Today, they’ve been largely replaced by safer alternatives, but a handful of barbiturates remain in clinical use for seizure control, anesthesia, and certain types of headaches.
How Barbiturates Work
Barbiturates enhance the activity of a brain chemical that dampens nerve signaling. The result is a dose-dependent slowdown of the nervous system. At low doses, this produces relaxation and reduced anxiety. At moderate doses, sedation and sleep. At higher doses, full anesthesia. And at doses not far above the therapeutic range, respiratory failure and death.
This narrow gap between an effective dose and a lethal one is the defining safety problem with barbiturates. Even a slight overdose can cause coma or death, primarily because the drug suppresses the brain’s drive to breathe. That risk is dramatically higher when barbiturates are combined with alcohol or other sedatives.
Types Based on Duration
Barbiturates are grouped by how quickly they take effect and how long they last:
- Ultra-short-acting: Used for anesthesia during brief medical procedures. Methohexital, for example, wears off in about 15 minutes when given intravenously.
- Short- to intermediate-acting: Butalbital falls into this range and is still found in combination headache medications, often paired with acetaminophen or aspirin and caffeine. It’s used for tension headaches and migraines.
- Long-acting: Phenobarbital is the main example. Its effects last hours, which makes it useful for ongoing seizure prevention.
What They’re Still Used For
During the 1930s and 1940s, barbiturates were at peak popularity, prescribed for everything from insomnia to anxiety. That changed in the 1950s and 1960s as newer psychiatric medications arrived, and especially after benzodiazepines offered a less toxic alternative for sedation and anxiety.
The remaining medical uses are narrow. Phenobarbital is prescribed to control seizures, particularly in certain forms of epilepsy, and occasionally to relieve severe anxiety. It also plays a role in managing withdrawal for people dependent on other barbiturates, where abrupt stopping would be dangerous. Butalbital-containing combination pills are still prescribed for headaches. And ultra-short-acting barbiturates see limited use as anesthesia induction agents for short procedures.
Why Barbiturates Are Tightly Controlled
The federal government classifies barbiturates across multiple controlled substance schedules depending on the specific drug and how it’s formulated. Pentobarbital and secobarbital are Schedule II substances, the same category as oxycodone, meaning they carry high potential for abuse and dependence. Phenobarbital sits in Schedule IV, reflecting somewhat lower (but still real) abuse potential. When pentobarbital or secobarbital are mixed with other active ingredients in combination products, those formulations may be classified as Schedule III.
These classifications mean prescriptions are closely monitored, refills are limited, and unauthorized possession carries serious legal consequences.
Dependence and Withdrawal
Barbiturates produce physical dependence relatively quickly when taken regularly. The body adjusts to their presence, and stopping abruptly can trigger a withdrawal syndrome that is genuinely life-threatening.
Withdrawal symptoms typically appear within 12 to 16 hours of the last dose and peak between one and three days later, though longer-acting barbiturates may delay the onset. Early symptoms include anxiety, restlessness, nausea, vomiting, weakness, and abdominal cramps. As withdrawal progresses, more dangerous symptoms can develop: rapid heart rate, severe tremors, involuntary muscle jerks, and generalized seizures. Barbiturate withdrawal belongs to the same medical category as alcohol withdrawal, and both can be fatal without proper medical supervision. Tapering off gradually under a doctor’s guidance is the standard approach.
How They Interact With Other Drugs
Beyond their direct sedative effects, barbiturates create a less obvious problem: they ramp up the liver’s drug-processing machinery. Phenobarbital in particular is a powerful inducer of liver enzymes responsible for breaking down many other medications. When those enzymes become more active, other drugs in your system get metabolized faster, which can make them less effective.
This matters for people taking blood thinners, hormonal birth control, certain heart medications, and many other prescriptions. If you’re on a barbiturate and another medication, the barbiturate may quietly reduce the other drug’s effectiveness without any obvious warning signs. This enzyme-boosting effect can also amplify the toxic potential of some substances by speeding up the conversion of inactive compounds into harmful byproducts.
Overdose Risk
Barbiturate overdose remains a serious clinical concern. The lethal mechanism is straightforward: the drug suppresses breathing to the point where the body can no longer take in enough oxygen. Secondary complications like pneumonia often follow in people who survive the initial respiratory failure but remain unconscious.
What makes barbiturates particularly dangerous compared to benzodiazepines is the lack of a reliable antidote. Benzodiazepine overdoses can be reversed with a specific medication, but no equivalent reversal agent exists for barbiturates. Treatment is supportive, focused on maintaining breathing and circulation until the drug clears the system. This fundamental difference in overdose safety is the primary reason benzodiazepines replaced barbiturates for most uses starting in the 1960s.